An Active Safety Surveillance Using Real-World Evidence (ASSURE) Approach to Pharmacovigilance Signal Evaluation: The Case of Paliperidone, Risperidone, and Low-Energy Fracture

被引：0

|

作者：

Bohn, Justin ^{[1
]}

Kern, David M. M. ^{[2
]}

Reps, Jenna ^{[3
]}

Knight, Karl ^{[1
]}

Killion, Leslie ^{[1
]}

Shearer, David M. ^{[1
]}

机构：

[1] Johnson & Johnson, Washington, DC USA

[2] Johnson & Johnson Innovat Med, Washington, DC USA

[3] Janssen Res & Dev LLC, Washington, DC USA

来源：

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2024年 / 33卷

关键词：

D O I：

暂无

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

1004 ; 120402 ;

摘要：

669

引用

收藏

页码：284 / 284

页数：1

相关论文

共 2 条

[1] An Active Safety Surveillance Using Real-World Evidence (ASSURE) Approach to Pharmacovigilance Signal Evaluation: The case of Infliximab and Alternative Autoimmune Conditions
Haynes, Kevin
Conover, Mitchell
Reps, Jenna
Smugar, Steve
Suruki, Robert
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2024, 33 : 523 - 523
[2] An Active Safety Surveillance Using Real-World Evidence (ASSURE) Approach to Pharmacovigilance Signal Evaluation: The Case of Methylphenidate and Potential Signal for Obsessive-Compulsive Disorders
Sarayani, Amir
Rao, Gowtham
Haynes, Kevin
Smugar, Steve
Siddiqui, Uzma H.
Bohn, Justin
Reps, Jenna
Conover, Mitchell
Kern, David M. M.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2024, 33 : 434 - 434